HIGHLIGHTS
- who: Federica Furfaro and colleagues from the (UNIVERSITY) have published the paper: Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD), in the Journal: (JOURNAL) of 20/06/2022
SUMMARY
In recent years, biologic therapy has gained increasing attention due to its proven efficacy in achieving clinical remission and mucosal healing and to prevent irreversible structural bowel damage. To biologics, small-molecule agents have gained acceptance in the treatment of IBD, including anti-JAK and anti-sphingosine 1 phosphate (S1P) drugs. For Etrolizumab (anti-β7), there are several phase 3 clinical trials evaluating . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.